Publications

Wagar MK, Reetz E, Huang D, Kao MJ, Al-Niaimi AN, Wallace SK, Barroilhet LM, McGregor SM. Patterns of primary metastasis and recurrence in mismatch repair deficiency and p53 abnormal endometrial carcinoma. Gynecol Oncol. 2025 Jun;197:171-178. doi: 10.1016/j.ygyno.2025.05.004. Epub 2025 May 12. PMID: 40359597.

Polaki US, Gilpin TE, Patil AT, Chiu E, Baker R, Liu P, Pavletich TS, Seifi M, Mañán-Mejías PM, Morrissey J, Port J, Welch Schwartz R, Ong IM, El-Rayes D, Khalifa MA, Hui P, Horner VL, Virumbrales-Muñoz M, Erickson BK, Barroilhet L, McGregor SM, Bresnick EH, Matson DR. Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma. JCI Insight. 2025 Apr 1;10(9):e187073. doi: 10.1172/jci.insight.187073. PMID: 40168074; PMCID: PMC12128953.

Shen L, Sadowski EA, Gupta A, Maturen KE, Patel-Lippmann KK, Zafar HM, Kamaya A, Antil N, Guo Y, Barroilhet LM, Jha P. The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection Rate. Radiology. 2024 Oct;313(1):e240044. doi: 10.1148/radiol.240044. PMID: 39377674.

Downs TM, Bailey HH, Lozar T, Schmitz NS, Green H, Scarlett CO, Havighurst TC, Twaroski K, DeShong K, Wollmer B, Bivalacqua TJ, Saltzstein DR, Shore N, Kim K, Huang W, Ricke WA, Barroilhet L, House M, Parnes HL, Messing E. Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery. Cancer Prev Res (Phila). 2025 Jan 6;18(1):31-39. doi: 10.1158/1940-6207.CAPR-24-0194. PMID: 39187984; PMCID: PMC11703677.

Sadowski EA, Lees B, McMillian AB, Kusmirek JE, Cho SY, Barroilhet LM. Distribution of prostate specific membrane antigen (PSMA) on PET-MRI in patients with and without ovarian cancer. Abdom Radiol (NY). 2023 Dec;48(12):3643-3652. doi: 10.1007/s00261-023-03957-3. Epub 2023 Jun 1. PMID: 37261441.

Sadowski EA, Rockall A, Thomassin-Naggara I, Barroilhet LM, Wallace SK, Jha P, Gupta A, Shinagare AB, Guo Y, Reinhold C. Adnexal Lesion Imaging: Past, Present, and Future. Radiology. 2023 Jun;307(5):e223281. doi: 10.1148/radiol.223281. Epub 2023 May 9. PMID: 37158725.

Kapur A, Ayuso JM, Rehman S, Kumari S, Felder M, Stenerson Z, Skala MC, Beebe D, Barroilhet L, Patankar MS. Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells. Reproduction. 2023 May 8;165(6):617-628. doi: 10.1530/REP-22-0265. PMID: 37068140; PMCID: PMC10601975.

Arend R, Dholakia J, Castro C, Matulonis U, Hamilton E, Jackson CG, LyBarger K, Goodman HM, Duska LR, Mahdi H, ElNaggar AC, Kagey MH, Liu A, Piper D, Barroilhet LM, Bradley W, Sachdev J, Sirard CA, O'Malley DM, Birrer M. DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma. Gynecol Oncol. 2023 May;172:82-91. doi: 10.1016/j.ygyno.2023.03.013. Epub 2023 Mar 29. PMID: 37001446.

Jha P, Gupta A, Baran TM, Maturen KE, Patel-Lippmann K, Zafar HM, Kamaya A, Antil N, Barroilhet L, Sadowski EA. Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United States. JAMA Netw Open. 2022 Jun 1;5(6):e2216370. doi: 10.1001/jamanetworkopen.2022.16370. PMID: 35679042; PMCID: PMC9185186.

Jamieson A, Barroilhet LM, McAlpine JN. Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape. Cancer. 2022 Aug 1;128(15):2853-2857. doi: 10.1002/cncr.34328. Epub 2022 Jun 3. PMID: 35657171.

Kapur A, Mehta P, Simmons AD, Ericksen SS, Mehta G, Palecek SP, Felder M, Stenerson Z, Nayak A, Dominguez JMA, Patankar M, Barroilhet LM. Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers. Cancers (Basel). 2022 May 5;14(9):2297. doi: 10.3390/cancers14092297. PMID: 35565426; PMCID: PMC9102822.

Gupta A, Jha P, Baran TM, Maturen KE, Patel-Lippmann K, Zafar HM, Kamaya A, Antil N, Barroilhet L, Sadowski E. Ovarian Cancer Detection in Average-Risk Women: Classic- versus Nonclassic-appearing Adnexal Lesions at US. Radiology. 2022 Jun;303(3):603-610. doi: 10.1148/radiol.212338. Epub 2022 Mar 22. PMID: 35315722.

Sobecki J, Weigman B, Anderson-Carter I, Barroilhet L, Chandereng T, Kliewer M, Hartenbach E. Opportunistic osteoporosis screening using routine computed tomography images to identify bone loss in gynecologic cancer survivors. Int J Gynecol Cancer. 2022 Aug 1;32(8):1050-1055. doi: 10.1136/ijgc-2021-003169. PMID: 35101963.

Micek HM, Carroll MJ, Barroilhet L, Kreeger PK. Processing and Analysis of Ascites. Methods Mol Biol. 2022;2424:95-104. doi: 10.1007/978-1-0716-1956-8_5. PMID: 34918288; PMCID: PMC9675583.

Liu J, Burris H, Wang JS, Barroilhet L, Gutierrez M, Wang Y, Vaze A, Commerford R, Royer-Joo S, Choeurng V, Humke E, Moore K. An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer. Gynecol Oncol. 2021 Dec;163(3):473-480. doi: 10.1016/j.ygyno.2021.09.023. Epub 2021 Oct 6. PMID: 34627611.

Uppal S, Medlin E, Felder M, Kapur A, Sterner RC, Vazquez J, Lindner PN, Stanic AK, Barroilhet L, Gonzalez-Bosquet J, Patankar MS. Identifying novel ovarian tumor biomarkers through mining of the transcriptome of circulating immune cells: A proof-of-concept study. Am J Reprod Immunol. 2021 Oct;86(4):e13469. doi: 10.1111/aji.13469. Epub 2021 Jul 2. PMID: 34022086.

Konstantinopoulos PA, Cheng SC, Wahner Hendrickson AE, Penson RT, Schumer ST, Doyle LA, Lee EK, Kohn EC, Duska LR, Crispens MA, Olawaiye AB, Winer IS, Barroilhet LM, Fu S, McHale MT, Schilder RJ, Färkkilä A, Chowdhury D, Curtis J, Quinn RS, Bowes B, D'Andrea AD, Shapiro GI, Matulonis UA. Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2020 Jul;21(7):957-968. doi: 10.1016/S1470-2045(20)30180-7. Epub 2020 Jun 15. PMID: 32553118; PMCID: PMC8023719.

Vazquez J, Chavarria M, Lopez GE, Felder MA, Kapur A, Romo Chavez A, Karst N, Barroilhet L, Patankar MS, Stanic AK. Identification of unique clusters of T, dendritic, and innate lymphoid cells in the peritoneal fluid of ovarian cancer patients. Am J Reprod Immunol. 2020 Sep;84(3):e13284. doi: 10.1111/aji.13284. Epub 2020 Jun 30. PMID: 32524661; PMCID: PMC7754790.

Patel-Lippmann KK, Sadowski EA, Robbins JB, Paroder V, Barroilhet L, Maddox E, McMahon T, Sampene E, Wasnik AP, Blaty AD, Maturen KE. Comparison of International Ovarian Tumor Analysis Simple Rules to Society of Radiologists in Ultrasound Guidelines for Detection of Malignancy in Adnexal Cysts. AJR Am J Roentgenol. 2020 Mar;214(3):694-700. doi: 10.2214/AJR.18.20630. Epub 2019 Nov 26. PMID: 31770022.

Sobecki-Rausch J, Barroilhet L. Anti-programmed Death-1 Immunotherapy for Endometrial Cancer with Microsatellite Instability-High Tumors. Curr Treat Options Oncol. 2019 Nov 21;20(11):83. doi: 10.1007/s11864-019-0679-5. PMID: 31754884.

Alharbi Y, Kapur A, Felder M, Barroilhet L, Stein T, Pattnaik BR, Patankar MS. Plumbagin-induced oxidative stress leads to inhibition of Na+/K+-ATPase (NKA) in canine cancer cells. Sci Rep. 2019 Aug 7;9(1):11471. doi: 10.1038/s41598-019-47261-x. PMID: 31391478; PMCID: PMC6685937.

Elezaby M, Lees B, Maturen KE, Barroilhet L, Wisinski KB, Schrager S, Wilke LG, Sadowski E. BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations. Radiology. 2019 Jun;291(3):554-569. doi: 10.1148/radiol.2019181814. Epub 2019 Apr 30. PMID: 31038410.

McCool KW, Sampene E, Polnaszek B, Connor J, Medlin EE, Barroilhet L. Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery. BMC Cancer. 2018 Oct 26;18(1):1041. doi: 10.1186/s12885-018-4882-8. PMID: 30367632; PMCID: PMC6204018.

McCool KW, Sampene E, Polnaszek B, Connor J, Medlin EE, Barroilhet L. Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery. BMC Cancer. 2018 Oct 26;18(1):1041. doi: 10.1186/s12885-018-4882-8. PMID: 30367632; PMCID: PMC6204018.

O'Shea A, McCool K, Harrison R, Sampene E, Connor J, Barroilhet L. Neoadjuvant chemotherapy is associated with more anemia and perioperative blood transfusions than primary debulking surgery in women with advanced stage ovarian cancer. Gynecol Oncol. 2018 Jul;150(1):19-22. doi: 10.1016/j.ygyno.2018.05.014. PMID: 29773300.

Barroilhet L, Matulonis U. The NCI-MATCH trial and precision medicine in gynecologic cancers. Gynecol Oncol. 2018 Mar;148(3):585-590. doi: 10.1016/j.ygyno.2018.01.008. Epub 2018 Feb 1. PMID: 29366510.